JPMorgan Chase & Co. Increases Stock Position in Teleflex Incorporated $TFX

Key Points

• JPMorgan Chase & Co. increased its stake in Teleflex by 41.5% in the third quarter to 123,343 shares (about $15.1M), and institutional investors now own roughly 95.62% of the company with several other funds also adding to their positions.
• Teleflex reported a weak quarter—EPS $1.93 versus $3.73 expected and revenue down 28.5% year-over-year—resulting in a negative net margin of 30.56%, though the company set FY2026 guidance of 6.25–6.55 EPS.
• Shares opened around $110.48 (market cap $4.88B) and the company pays a quarterly dividend of $0.34 (1.2% yield); analyst coverage is mixed with an average rating of "Hold" and an average price target of $140.83.

JPMorgan Chase & Co. boosted its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 41.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 123,343 shares of the medical technology company's stock after purchasing an additional 36,178 shares during the period. JPMorgan Chase & Co. owned approximately 0.28% of Teleflex worth $15,092,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Russell Investments Group Ltd. grew its stake in shares of Teleflex by 23.6% during the second quarter. Russell Investments Group Ltd. now owns 83,388 shares of the medical technology company's stock valued at $9,870,000 after acquiring an additional 15,935 shares in the last quarter. Capital International Investors acquired a new position in shares of Teleflex in the third quarter worth about $44,851,000. Public Sector Pension Investment Board boosted its holdings in Teleflex by 24.9% in the third quarter. Public Sector Pension Investment Board now owns 188,208 shares of the medical technology company's stock valued at $23,029,000 after purchasing an additional 37,539 shares during the last quarter. Invenomic Capital Management LP boosted its holdings in Teleflex by 35.6% in the third quarter. Invenomic Capital Management LP now owns 385,672 shares of the medical technology company's stock valued at $47,191,000 after purchasing an additional 101,287 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its stake in Teleflex by 113.9% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 58,047 shares of the medical technology company's stock valued at $7,366,000 after purchasing an additional 30,912 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company's stock.

Teleflex Trading Up 2.1%

NYSE:TFX opened at $110.48 on Friday. The company has a market cap of $4.88 billion, a PE ratio of -5.38, a P/E/G ratio of 0.67 and a beta of 0.87. The business's 50 day moving average is $108.80 and its two-hundred day moving average is $116.86. The company has a quick ratio of 2.01, a current ratio of 2.54 and a debt-to-equity ratio of 0.81. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $141.91.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share for the quarter, missing analysts' consensus estimates of $3.73 by ($1.80). Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The firm had revenue of $569.00 million during the quarter, compared to the consensus estimate of $912.57 million. During the same quarter last year, the firm posted $3.89 earnings per share. Teleflex's revenue was down 28.5% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 6th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Friday, March 6th. Teleflex's dividend payout ratio is -6.62%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on TFX. Royal Bank Of Canada upped their target price on Teleflex from $115.00 to $125.00 and gave the company a "sector perform" rating in a research report on Friday, February 27th. Zacks Research downgraded shares of Teleflex from a "hold" rating to a "strong sell" rating in a research report on Monday, March 2nd. Wall Street Zen lowered shares of Teleflex from a "hold" rating to a "sell" rating in a research note on Saturday, March 7th. Needham & Company LLC increased their price objective on shares of Teleflex from $138.00 to $147.00 and gave the company a "buy" rating in a research note on Thursday, February 26th. Finally, Truist Financial raised their price objective on shares of Teleflex from $120.00 to $135.00 and gave the stock a "hold" rating in a report on Thursday, December 18th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $140.83.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.